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Abstract
Background: This paper presents the outcomes from a workshop of the European Network
on the Health and Environmental Impact of Nanomaterials (NanoImpactNet) held in June
2008. During this workshop 45 experts in the field of safety assessment of engineered
nanomaterials from academia, nonprofit organizations and industry addressed a list of
essential metrics of engineered nanomaterials that need to be characterized as a minimum.
Results: The group discussed the need to systematically study sets of engineered
nanomaterials to generate a dataset that allows for the establishment of doseresponse data
related to specific metrics of engineered nanomaterials. Concomitantly the availability of
analytical methods to determine the physicochemical characteristics was discussed. Given
the measurement challenges specific for engineered nanomaterials the issue of harmonizing
protocols was raised.
Conclusion:

The

group

concluded

that

international

cooperation

and

worldwide

standardization of terminology, reference materials and protocols are needed to make
progress in establishing lists of essential metrics. The need for high quality data necessitates
the development of harmonized study approaches and adequate reporting of data. Priority
metrics can only be based on wellcharacterized doseresponse relations (as regards
biological interactions and physiochemical characteristics) of engineered nanomaterials. This
requires the systematic study of the biokinetics and biointeractions of nanomaterials at both
organism and (sub)cellular levels. Additionally, much effort needs to be put into the
standardization and validation of analytical methods to determine these metrics. Especially
for the characterization of engineered nanomaterials in a complex matrix much work needs to
be done.
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Background
The field of nanotechnology is rapidly developing and engineered nanomaterials (ENMs) are
already applied within industrial applications and consumer products. This will lead to many
new products possessing new and exciting features that are not realisable using conventional
forms of chemicals. Consumer exposure to ENMs is very likely to occur, while it needs to be
acknowledged that different applications of ENMs in different products have a differential
likelihood of exposure. Although the obvious beneficial effects of nanotechnologies are well
recognised, the potential human and environmental toxicological effects and impacts of
ENMs have so far received little attention [1, 2]. There is a growing body of evidence to
suggest that new interaction processes may occur between biological systems and
engineered ENMs [3].
As a consequence of their small size, ENMs can exhibit different physicochemical properties
and biological effects compared to their respective bulk materials, even at the same mass
dose [4]. At present, researchers have not been able to establish a single parameter that best
describes the dose and the observed doseresponse relationship for toxicological testing.
Instead a variety of physicochemical parameters have been suggested to contribute to the
biological behaviour of ENMs see [5, 6]. Given this uncertainty, a full characterisation of
ENMs is essential in order to relate the possible benefits as well as the potential toxicity of
ENMs in both human and ecological systems to the specific features of ENMs [79], not only
at production and in buffer suspensions, but also in the complex biological medium relevant
to the test system [10].
The ability to fully characterize the ENMS is severely limited by the limitations of the presently
available analytical methods. Generally, with the available methods, only a single
characteristic of an ENM can be determined in one run. The workshop of the European
Network on the Health and Environmental Impact of Nanomaterials (NanoImpactNet [
http://nanoimpactnet.eu]) focused on making progress in this area by trying to reach
consensus on the minimal analytical characterisation of engineered nanomaterials needed for
hazard assessment in biological matrices. During the workshop 45 experts in the field of
safety assessment of engineered nanomaterials from academia, nonprofit organization and
industry addressed this issue.
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Standardisation. The need for standardisation and prioritization of protocols and materials in
the field of nanotechnologies is well acknowledged by a number of major organisations (e.g.
The Organisation for Economic Cooperation and Development [OECD] and the International
Standards Organisation [ISO]). This was highlighted by Peter Hatto, who is the chair of the
ISO technical committee on nanotechnologies (TC 229). This technical committee contributes
to the development of standards in the areas of terminology, nomenclature, metrology and
characterisation, and environmental health and human safety of ENMs to support regulatory
regimes, research, commercialisation and trade in nanomaterials. Realisation of the widely
recognised need for standardisation is currently difficult because there is no agreed
terminology, no reference standard materials for toxicity testing and there are no protocols
available for (reproducible batchtobatch) ENM production, characterisation and hazard
assessment, and indeed no consensus exists yet regarding the minimum set of information
needed to characterise ENMs.
The ISO and OECD activities have full industry support. For producers standardisation and
characterisation are very important for the quality of products containing ENMs. Development
of clear terminology is to their advantage given the diversity of applications as indicated by
representatives from industry: the possibility to produce materials of light weight but suitable
for extreme conditions, more efficient solar cells, materials to protect against environmental
degradation and targeted drug delivery. Numerous ENMs are currently used in these
applications, such as metal oxide ENMs (e.g. ZnO, TiO2, SiO2), quantum dots and carbon
ENMs, like (C60) fullerenes and carbon nanotubes (CNTs).
Christoph Klein from the European Commission Joint Research Centre added views from a
regulatory, risk assessment perspective. For this the lists of physicochemical parameters as
prepared by both OECD and ISO are very important. These lists are derived from currently
existing requirements for conventional chemicals with the inclusion of other specific
characteristics of ENMs, such as surface area. There is currently no consensus within the
scientific community on which characteristics should be determined with higher priority.
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Metrics and dose response relations. Consensus on the minimal characterisation of ENMs
can only be reached on the basis of a sound understanding of the mechanisms of interaction
of ENMs with biological systems. According to Vicki Stone (Professor of Toxicology and
(co)director of the Biomedicine & Sports Science Research Group, Napier University,
Edinburgh, UK) biological interactions of ENMs cannot be attributed to one single parameter/
characteristic. Several physicochemical factors have been related to biological responses;
e.g. size, surface area, high aspect ratio, charge, solubility, surface chemistry and reactivity.
Within the literature attempts have been made to establish dose response relations for
various physicochemical properties and observed effects of ENMs. Some examples of dose
response relations are mentioned below. As a generalised pattern, it is observed that ENMs
of chemical elements with low toxicity and low solubility induce reactive oxygen species
(ROS) and proinflammatory cytokine release (see for example [11]).
[12] showed a size dependent TiO2 pulmonary clearance (T1/2) in rats exposed to aerosolized
materials. The relation between physicochemical properties (size, surface area, crystal
phase) of TiO2 and ROS production was further substantiated in the systematic assessment
by Jiang and colleagues [13]. Both Wilson, Stone and colleagues [14, 15] showed size
dependent induction of oxidative stress by carbon black (although the study by [15] used
equivalent masses e.g. the number of particles increases as the particle sizes decreases).
Size dependent induction of ROS was also observed by Brown and colleagues [16] using
polystyrene particles (also using equivalent masses). Lung inflammation following exposure
to particulate air pollution (PM10) also shown to be sizedependent [17, 18]. In all of these
studies, toxicity was shown to increase with decreasing ENM particle size.
A specific feature of ENMs is the large surface area and thus high proportion of surface
atoms. Surface area has been suggested to be an important metric for the induction of
inflammation by low solubility particles such as carbon, TiO2 and polystyrene beads [16, 19
21]. Good correlations with dose were also shown when expressing different sized materials
(carbon black and TiO2) as surface area in a study on oxidative stress induction [22].
Expression of dose as surface area is an interesting alternative to mass dose, especially
when considering exposure. For example, the uptake of differently sized ENMs by Daphnia
magna, suggests that mass uptake of 20nm polystyrene nanoparticles is much lower than for
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1000nm particles, but when expressed as surface area the two are almost identical
(Rosenkranz et al., manuscript in preparation). In the studies as performed by Duffin [19, 21]
using low toxicity particles such as carbon black, titanium dioxide and polystyrene particles,
there was a linear relationship between surface area dose instilled into the rat lung and the
resultant neutrophil influx which was not related to the mass of the particles. In these studies
the intrinsic toxicity of the particles was also shown to play a role, as expected, in that
relatively toxic alphaquartz silica particles induced a relatively more severe inflammation
than low toxicity particles with the same surface area, which suggests that quartz has a more
reactive surface, and that therefore the inflammogenic potential is a function of both particle
surface area and surface reactivity.
In the case of carbon nanofibre/nanotube (CNT) induced effects, the nanomaterial
morphology including length of fibres and state of aggregation is important for determining
uptake processes by macrophages. Long (50mm) straight nanotubes were not effectively
taken up by the macrophages, resulting in frustrated phagocytosis as indicated by an
increase in the production of superoxide anion radicals, and inflammatory signalling as
indicated by TNFa production [23]. Entangled nanotubes were easily and extensively
phagocytosed and therefore did not affect ROS or TNFa production by the macrophages.
Subsequent studies using CNTs have also shown that longer nanotubes induce
intraperitoneal inflammation and granuloma formation associated with the mesothelial lining
of the body cavity in mice, whereas no effects were observed following exposure to shorter
entagled tubes [24]. This data suggests that nanotubes might behave according to the fibre
toxicity paradigm, which highlights that respirable fibres which are biopersistent and possess
an aspect ratio (ratio between length and thickness) of greater than 3:1 and a length of
greater than 15mm are more likely to induce fibrosis and cancer than shorter or soluble fibres.

Measurement challenges. Nanomaterials have specific, unique, measurement challenges.
This was exemplified by Hugh J. Byrne, Director of the Focas Institute of the Dublin Institute
of Technology with data on the assessment of single walled carbon nanotubes (SWCNTs)
toxicity. In their studies a variety of analytical techniques were used. For example,
transmission electron microscopy (TEM) analysis shows that SWCNTs were not internalized
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by A549 human epithelial lung cells, but that bundles of tubes adhered to the cells. These
different interactions might explain the large variability in toxicological effects and TEM
analysis proved to be the right technique to elucidate this phenomenon [25]. TEM with
electron energy loss spectroscopy yield valuable information regarding the nanomaterial and
its environment. Confocal microscopy of ENMs in species like Daphnia magna can be used
to track and identify nanomaterials [26], but is often not very sensitive. In general,
spectroscopic techniques can be used and could in the future offer high throughput
techniques with relatively lower capital and personal cost. This however is dependent on
identifying indicators or markers of ENMs toxicity that can be picked up using spectroscopic
techniques.
To assess directly cytotoxicity, colorimetric (e.g. spectroscopic) techniques are frequently
used as read out systems. In the case of SWCNTs this might be problematic because CNTs
interact with the dyes used for colorimetric assays [27].This interference might severely limit
the reliability of the outcome for assays in which dyes are used. Hugh Byrne stated
“everything” sticks to carbon nanotubes, even components from cell culture media, thereby
likely interfering with the outcome of assays (e.g. cytotoxicity) (e.g. [28]. Given the limitations
of these toxicology tests, alternative screening approaches need to be developed for CNTs,
such as the clonogenics assay that has been demonstrated as a potential alternative [29].
Other possibilities include Fourier transform infrared spectroscopy and Raman spectroscopy
which are both increasingly used for diagnostic and biochemical analyses in conjunction with
multivariate statistical tools [30]. Raman spectroscopy requires minimal sample preparation
and, in most cases, the samples are recoverable allowing it to be used and compared with
other important techniques. There are, however, also drawbacks for the Raman technique.
Firstly, it requires a clear marker, or indicator in order to complete a quantitative analysis and
this marker or the ENM needs to be Raman active. Secondly, the Raman effect is quite weak
and the limit of detection is highly dependent on the material under investigation (CNTs are
highly Raman active but TiO2 is not). Therefore, it may not be useful as a generic technique.

Objectives
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Following the introduction of the subjects,, participants were asked to address the following
specific issues (see Annex 1 for a list of speakers and titles of their presentations):
1) Standardisation: What are priority engineered nanomaterials?
2) Future perspectives on metrics, dose response relations. Is there a common, effect
driven metric within reach (e.g. surface area, biomolecular corona)?
3) Measurement challenges specific to engineered nanomaterials.
4) Priority directions for research with respect to alternative approaches. What other
‘detection’ approaches can be used, if instrumental detection is not feasible?
For the discussions the workshop, employed multidisciplinary breakout sessions with two
randomly generated groups to consider these questions in detail. Outcomes of discussions
were summarized and briefly discussed at the plenary at the end of the workshop. The
discussions were guided by a number of predefined questions and managed by an
appointed chair and rapporteur. Consensus of viewpoints was noted but not required.
Different viewpoints have been captured in the discussions.

Results
Standardisation: Priority engineered nanomaterials. Worldwide standardization of
terminology, reference materials and protocols is needed to develop a minimum set of
characterisitics of ENMs to be determined. It was pointed out that all international and
national regulatory and standards bodies should work together to address these issues (see
also [31]. Commercially available ENMs are very variable in ENMs characteristics, with
different chemical composition, size, shape and contamination/impurities including batch to
batch variability, as well as the differences arising from different synthesis routes (e.g. use of
other surfactants and therefore other protein adsorption behaviour). Perhaps with the only
exception of C60 fullerene (which is clearly defined), the variation in types of ENMs is huge.
Therefore, it is rather difficult to make general statements regarding reference materials and
the toxicity associated with ENMs.

Lists of engineered nanomaterials. Over the past few years, several lists of priority ENMs
have been published. The most prominent is the OECD list (Table 1). When constructing this
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list the OECD took into account those materials which are in, or close to, commercial use, as
well as other criteria including, production volume, the likely availability of such materials for
testing and the existing information that is likely to be available in dossiers on such materials.
Thus the OECD list could be perceived as a list driven by industry needs. The International
Council on Nanotechnology (ICON) used this list as a starting point, but they went on to
prioritise further the most produced nanomaterials, which were then considered the most
important group.

Table 1  OECD List of representative manufactured nanomaterials for testing
(OECD; ENV/JM/MONO(2008)13)
• Fullerenes (C60)
• Singlewalled carbon nanotubes (SWCNTs)
• Multiwalled carbon nanotubes (MWCNTs)
• Silver nanoparticles
• Iron nanoparticles
• Carbon black
• Titanium dioxide
• Aluminium oxide
• Cerium oxide
• Zinc oxide
• Silicon dioxide
• Polystyrene
• Dendrimers
• Nanoclays
Note: The order in which the nanomaterials are listed above does not indicate a priority.

The OECD list forms a starting point in various discussions related to nanosafety and
nanorisk assessment and is used in setting many research agendas. During the discussion,
several issues were raised. Inevitably with any list, important nanomaterials can be
overlooked, and newly emerging ENMs are not included due to the constant rapid
development of nanotechnologies. Moreover, the relevance of these lists for risk assessment
purposes was questioned during the discussion as the list represents primary nanomaterials
(as produced nanomaterials) and does not assume a priori that toxicity will be observed at
realistic dose levels. This raises questions about the validity of test methods developed, as
no observed effects may be due to the ENM not being toxic or a result of the test not being
adequate for ENM. Separating these issues will be challenging. It was concluded that
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concomitant with using the OECD priority list of ENMs, other aspects should be taken into
consideration when preparing a list of priority ENMs. These aspects are listed in Table 2.

Table 2 – Proposal for lists of ENMs that require prioritisation

List of ENMs

Description

Scientific

Which nanomaterials should be used to study mechanisms of action or
scientific paradigms? It was argued that ‘ad hoc’ constructed materials
which have specific characteristics, such as being fluorescently labelled, will
be extremely helpful for mechanistic research questions. Alternatively, for
risk assessment purposes, research should focus on ENMs in the form they
have in the environment or in the matrix where they occur.

Availability

Taking nano silver as an example, it was remarked that some ENMs should

for

be given high priority because of the high expected consumer exposure,

consumers

their widespread commercial availability, and thus their expected high
volumes of use. This triggered a discussion on the need of a market driven
priority list like the ICON list.

Consumer

It was recognised that the different types of application for the variety of

concern

nanomaterials currently available may trigger different degrees of consumer
concerns (for example, the comparison of the use of nanomaterials in
medical settings against their use within food applications and the resulting
different riskperception by consumers). Different applications may give rise
to different degree of consumer concern,. Therefore the inclusion of
anticipated consumer concern as a criterion for the selection of priority
nanomaterials could be very illustrative.

Perspectives on metrics: which characteristics of ENMs should be determined? The
great challenge now is, firstly to prioritise some metrics based on biological dose response
relations and, secondly, to develop less labour intensive analytical methods to characterise
ENMs in biological matrices. During the group discussion it was identified that, in principle, for
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most, if not all, characteristics of ENMs, analytical methods are available [3234]. The issue,
however, is that these methods are normally only able to determine one single characteristic,
making the process of full characterisation very labour intensive. This leads to the conclusion
that currently not all ENMs characteristics can be readily determined. Furthermore, different
techniques that are available to measure the same nanomaterial characteristic can produce
contrasting results (e.g. reported sizes of ENMs) – the variations typically emerge as a result
of intrinsic biases and modelling assumptions of the techniques. Agreement on standard
testing methods is lacking and the comparability between different methods to assess a
specific metric is still being evaluated. Even using reference materials, such as size
standards, significant differences in the size are reported using different techniques (NIST,
2007). Therefore, it is recommended to clearly describe in all study reports which method
was used and under which circumstances.
Although it was generally agreed by the participants of the workshop that one metric is not
sufficient, it is vital that those metrics which have been previously used (e.g. size,
morphology, mass, surface area, aspect ratio, charge, solubility and surface chemistry) are
evaluated. It is important that a focused and validated list of metrics is initially proposed and
progress is made from that point onwards. In addition, it is important to know which
parameters can be altered without changing ENMinduced biological effects (e.g. which
metrics are of lesser significance). The metrics must be practical, and easy to characterise,
reproducible and applicable to the ENM as it will be used in subsequent toxicity tests. A
pragmatic way forward might be to characterise fully the ENMs at production. At subsequent
stages the group deemed it sufficient to asses a very limited set of parameters before use
(exposure) in the exposure medium, in order to take into account the effects of different
environments/conditions including effects of storage and sterilisation and adsorption of
biomolecules on the physicochemical characteristics of ENMs [35, 36]. It is, however,
important to note that subtle effects such as changing surface charge might need additional
investigation as recent findings show that such small changes can have a significant impact
on the biological response [37]. Specific problems encountered in characterising ENM
dispersions are the agglomeration / aggregation state in suspensions and the interactions of
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ENMs with the surrounding matrix before and during exposure, which need to be studied and
reported.

Box 1 – Definition of Agglomeration or Aggregation [38].
Definitions:
Agglomerate: A group of materials held together by weak forces such as van der Waals
forces, some electrostatic forces and or surface tension.
Aggregate: A group of materials held together by strong forces such as those associated with
covalent or metallic bonds.
It was accepted that not all characteristics that can be measured are necessary for all
purposes. For example the use of data for predictive toxicology metrics requires as much
data as possible while for industry (production) requirements are likely to be less demanding,
and even for the assessment of risks this might be the case. When reporting data on the
characterisation of ENMs it is important that a rationale is presented regarding the choice to
focus on a selected metric. Furthermore, any use of surface modification using ligand
molecules, surfactants, stabilizing counter ions, surface coatings etc. must be reported.
The group concluded to propose a list of metrics which (minimally) should be described in
every study related to the health impact of nanomaterials. Only this ensures that the findings
can be used by other related domains, and to enable comparisons between studies and ENM
and cell / tissue / animal combinations. The list is presented in Table 3.

Table 3  List of minimal characteristics and metrics recommended for every field of research
investigating the health impact of nanomaterials and metrics that may be useful for specific
fields. This may be reduced in the future as more knowledge becomes available.
Characteristic

Metric

Challenges and comments

Size distribution (of

Diameter – not

 Different measurement methods investigate

primary particles)

appropriate for high or

Essential metrics

different submetrics, e.g. mobility diameter
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even medium aspect
ration ENMs.

vs. visual diameter.
 Distribution of sizes needs to be reported.
 Nanomaterials can agglomerate or
aggregate (see box 1 for definition).
 Nanomaterials coated (e.g. corona) with
biomolecules, depending on matrix – which
diameter to assess?
 Depend on medium

Chemical

Chemistry

composition

 Chemical composition can be determined,
but structural information is difficult to obtain
due to complex measurements, ideally this
would be provided by manufactures,

Purity/impurities

 Impurities may be as important for health
impact as the basic material

Nanomaterial

Surface area

surface

 Different measurement methods investigate
different submetrics, e.g. BETsurface,
Fuchs's surface, visual surface, mobility
diameter surface.

Chemistry

 There are no simple methods to assess the
chemistry of nanomaterials surface. Thus,
provide at least information on the synthesis
method used, and if / what surface
treatment or stabilisation method had been
used.

Surface Charge

 Zeta potential and pH measurements should
be reported for all particles in appropriate
test media.

Structure

Agglomerate size

 Agglomeration status is in equilibrium with
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(distribution)

the matrix. No commonly agreedon metric
exists to define the agglomeration status.
Also, information about the stability of
agglomerates in different media would often
be very useful. Aggregation is a more fixed
status, and should not be mixed up with
agglomeration.

Often important metrics

Shape

Aspect ratio

 Aspect ratio determines if an object falls
within the WHOdefinition of a fibre, and is
very important for health impact assessment
purposes.

Persistence

Solubility

 These different types of metrics give

UVstability

information about the persistence of

thermalstability

materials in biological media, and
environmental compartments. These factors
(UV, heat) may also affect ENM surface
properties and agglomeration.

Dose response relations. It is essential that further research is devoted to determining dose
response relations (e.g. biokinetics and biodynamics), in order to be able to identify
biologically relevant metrics. It was agreed that it may be possible to derive general effect
patterns of ENMs from a wide range of studies, especially if these studies use exactly the
same ENM (same source, same batch & lot number) in combination with studies using a
range of different forms/shapes (i.e. carbon nano tubes with different shapes), and analysed
coherently. These systematic studies might subsequently be used for readacross and
modelling purposes. For this, a robust physicochemical characterisation is a prerequisite.
However, it was also noted that once in contact with living systems, ENM are immediately
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coated with proteins and other biomolecules implying that direct physiochemical
characterisation alone may not be the sufficient in terms of a realistic characterisation for
mechanistic studies[39].
To successfully perform such systematic studies it was recognized by the participants of the
workshop, that it is important to fill in the gaps in the current OECD guidelines, including any
decision regarding which endpoints to investigate, the procedure to measure dose, and the
best approach to the characterisation of ENMs, including at which point in the studies
characterisation should be conducted, i.e. at production, at exposure internally, or before and
after the test. It was acknowledged that the amount of information that can be requested from
producers is not unlimited from a practical point of view.
Moreover, for the interpretation in terms of relevance for hazard assessment, the use of high
doses in the majority of the tests was challenged, similar to the current situation in the testing
paradigms of conventional chemicals. For in vivo studies, biokinetics is a challenge, e.g.
some ENMs might simply dissolve during transport in bodily fluids such as the contents of the
gastro intestinal tract.

Practical and measurement challenges specific to nanomaterials. For reliable studies
with ENMs the availability of stable suspensions and harmonized dispersion protocols was
considered very important by the group. The following methods are currently widely used for
dispersing ENMs:
·

Ultrasonication (by use of a ultrasonic bath or tip);

·

Shaking and vortexing;

·

Various solvents;

·

Use of dispersants.

Concern was raised about the use of standardised dispersion protocols. Some interlaboratory
variance in the protocols used is valuable/necessary for scientific progress. Obviously,
researchers need to be mindful of the experiments being carried out. In some cases the
harmonised protocols should be adapted to suit the ENMs to be studied and the
cells/organisms/animals being used. The precise methods used to disperse ENMs should be
specifically, yet succinctly described within the experimentation section of a publication.
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Dispersing agents such as surfactant are sometimes utilised to facilitate the dispersion of
ENMs [40]. This, however, might alter the resulting toxicological effects, and test of the
dispersing agent at appropriate concentrations should be conducted in parallel as controls.
Furthermore it was noted that the details of these dispersion aids and their effects on end
measurements need to be incorporated within any materials sections published. A further
note was made that the effect of sonication, or any other preparation technique should also
be considered and appropriate controls included in the experimental design as there may be
issues related to “fresh” surfaces having higher reactivity.
Some suitable methods to characterise the degree of dispersion of the ENMs were
discussed. Clearly, one should not fully rely on one technique only, but rather multiple
measurements from at least two analytical approaches (e.g. techniques) should be employed
to characterise ENMs dispersions. Dynamic Light Scattering, Transmission and Scanning
Electron Microscopy, Atomic Force Microscopy were all identified as suitable techniques (see
also[8, 33, 34, 41, 42], although the microscopy techniques typically measure the dry
materials rather than the dispersion. To assess the agglomeration state the only method is
cryoTEM, in which the sample is frozen in liquid helium and observed by TEM in the frozen
state. Analytical centrifugation is also being developed as an alternative approach.
More challenging is the characterisation of ENMs in biological matrices (e.g. tissues, food,
soil). It was recognized that there is currently no standard approach/protocol for sample
preparation to control agglomeration/aggregation and (re)dispersion upon transfer from the
“asprovided” state to the test medium. This was highlighted as an issue which needs to be
addressed, but also that a pragmatic solution is not readily achievable in the short term, as
there is no single solution for all ENM due to their enormous diversity. Much progress on
harmonisation and exchange could be gained by addressing day to day issues/problems.
Given the current difficulties in detection and characterisation of ENMs, adding a label could
be a way of facilitating the study of the (internal) fate of ENMs in biological tissues. Several
labelling and/or imaging techniques are possible, such as magnetic labelling, neutron
activation, electromagnetic resonance spectroscopy?? and fluorescentlabelling. In this
context it is essential that the ultimate fate and the effect of the label are known, and that
introduction of the label does not fundamentally change the physicochemical characteristics
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of the ENM, as otherwise there is no correlation to the unlabelled version. A recommendation
was made not to rely on technologies which employ biopersistent materials like for instance
insoluble iron oxide ENM. Moreover, the example of nanosilver was discussed, given its
ability to form silver ions readily in a variety of different environments with the result that the
test material may change from nanosilver to ionic silver [43]. The conclusion of the
discussion was that all experimental scientists need to ensure that the ENM that is
characterised is similar to the ENM that is presenting itself to the entity under test (in vitro/in
vivo), by monitoring the form and state of the test nanomaterial using correct analytical
techniques at the various stages of sample preparation, pre and postexposure.

Priority directions for research into alternative measurement approaches. Currently no
standard analytical equipmentbased approaches have been established for the
characterisation of ENMs. The evaluation of possible alternatives at this stage is a difficult
task and it is unclear if there are at present any alternatives to instrumental detection. Bio
markers may provide information on response and the degree of a response but not on the
dose (i.e. it will not be possible to distinguish between a low dose of a very reactive species
and a high dose of a low reactive species). Yet, no generalized biological response specific to
ENM exposure (or even a series of responses or markers) which can act as indicators has
been identified. The group concluded that at the current stage of development it is seen as
unrealistic that noninstrumental based systems such as biomarkers can offer anything other
than a supporting role to detailed multitechnique based studies on establishing the indicators
of ENM toxicity. Highly specific (next generation) ENMs may support the notion of
establishing response specific phenomena in biological systems. Techniques in
biotechnology, such as gene expression and engineered microorganism (e.g. bacteria) might
offer an insight into how such systems could work, offering a battery of responses from
biological systems (e.g. a finger print of the ENM in a biological matrix). Cross reading
approaches (like quantitative structure activity relationships [QSAR]) allow the prediction of a
substance toxicity using a computer model. The system is still under development for
conventional chemicals and is driven by the REACH initiative. Potentially such an approach
could work for ENMs using the physiochemical properties integrated with doses response

18

information from biokinetic and biodynamic studies. Clearly, these approaches are important
and could be a long term goal for simple ENMs. However, ENMs can be complex products
whose properties evolve over time and thus the implementation of QSARlike approaches in
nanotechnology may be a difficult task. To make progress in the cross reading approaches
toxicological data and data on ENM characteristics need to be collected in freely available
databases that allow for a systematic analysis of all scientific data. Such databases need
careful consideration and require strict control over the data quality and reporting of all
appropriate experimental details and full characterisation. Networks like NanoImpactNet, with
its associated members, will be important facilitators for this process.

Conclusions/ recommendations
The interdisciplinary discussions in this workshop led to the following conclusions and
recommendations:
Standardisation: Priority engineered nanomaterials
·

Due to high batch variability of commercially available and to a lesser degree laboratory

made ENMs it is not possible to make general statements regarding the toxicity resulting from
exposure to ENMs.
o

It was recommended that the OECD priority list of ENMs should be complemented
with ENM selected by other criteria such as suitability for mechanistic (scientific)
studies or risk assessmentbased studies, widespread availability (and thus high
expected volumes of use) or provoking consumer concern (route of consumer
exposure depending on application).

Priority metrics
·

It was concluded that the first big challenge is to prioritise metrics based on biological

dose response relations and secondly, to develop analytical methods for characterising
ENMs in biological matrices.
·

It was generally agreed that one metric is not sufficient to fully describe the ENMs.
o

It is recommended that initially similar well characterised batches of ENMs with
varying forms/ shapes are used in a wide range of effect studies, before deciding
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what metrics are most important. Subsequently, this process needs to be
systematically repeated with other sets of priority ENMs.
o

It is expected that a systematic a analysis of the data will allow an assessment of any
relationships between observed effects and physicochemical characteristics of
ENMs.

Standardisation: Characterisation techniques
·

For most, if not all, characteristics of ENMs, analytical methods are available, though not

necessarily validated and standardized. Practically, it is currently not feasible to characterise
ENMs fully, because generally individual methods are only able to determine one single
characteristic and some of them can be rather expensive. In addition an agreement in respect
to what constitutes a complete ENM characterisation has yet to be reached.
·

It was concluded that the type of matrix that surrounds the ENM might critically influence

the appearance of the nanomaterial and its interaction with the surrounding matrix. This
further complicates the characterisation problem.
o

It is recommended that, where possible, at least two analytical approaches (e.g.
techniques) are used to determine a given metric of ENMs (e.g. measuring the same
parameter), because available techniques to measure the same nanomaterial
characteristic often produce contrasting results.

o

It is recommended that the techniques used to determine physicochemical
characteristics and methods used for (re) dispersion are clearly stated in the methods
sections of published studies.

Standardisation: Characterisation approaches
·

It was concluded that ENMs need to be characterised in the matrix as it is presented to

the test system (in vitro/ in vivo).
o

A pragmatic recommendation is to characterise fully the ENMs at production, and
subsequently further explore a very limited set of parameters before use (or
exposure), in order to take into account the different environments/conditions
including effects of storage and sterilization on the physicochemical characteristics of
ENMs.
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·

It was concluded that there is currently no standard approach/protocol for sample

preparation to control agglomeration/aggregation and (re)dispersion.
o

It is recommended that harmonization is initiated and exchange of protocols takes
place. The precise methods used to disperse ENMs should be specifically, yet
succinctly described within the experimental section of a publication.

·

The use of dispersing agents as surfactants to facilitate the dispersion of ENMs might

alter the toxicological effects.
o

Therefore it is recommended that details of these extra dispersion aids should be
incorporated within any materials sections published, and their toxicity tested in
parallel with the ENM.

·

It was concluded that labelling of ENMs could be a way of facilitating the study of

(internal) fate of ENMs in biological tissues. The ultimate fate and effect of the label needs to
be known and it is recommended that no reliance is put on technologies which employ bio
persistent materials.
Alternative measurement approaches.
·

It was concluded that alternative approaches (e.g. biological or in silico systems) for the

characterisation of ENMS are simply speculation at the present time, given the lack of
experimental data against which to test and validate the outcome of alternative approaches.
·

It was recognized that gene expression studies (omics) could lead to the identification of

biomarkers, but is was noted that at the current state of development that these approaches
only have a supporting role to detailed multitechniquebased toxicological studies.
o

To make progress in the cross reading approaches it is recommended to collect
toxicological data and data on ENM characteristics in freely available databases
(open science) that allow for a systematic analysis of all scientific data. Such
databases need careful considerations and require strict control over the data quality
and reporting of all appropriate experimental details and full characterisation. It was
recognized that these developments are a long term goal even for simple ENMs.
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